Publication

Byline

Location

US Patent Issued to INSTITUT CURIE, MNEMO THERAPEUTICS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE on May 12 for "Immunotherapy targeting tumor neoantigenic peptides" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,926, issued on May 12, was assigned to INSTITUT CURIE (Paris), MNEMO THERAPEUTICS (Paris) and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCH... और पढ़ें


US Patent Issued to Iovance Biotherapeutics on May 12 for "Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy" (Florida, California, Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,927, issued on May 12, was assigned to Iovance Biotherapeutics Inc. (San Carlos, Calif.). "Processes for production of tumor infiltrating ly... और पढ़ें


US Patent Issued to Seoul National University R&DB Foundation, Sungkwang Medical Foundation on May 12 for "Nanovesicles from adult stem cells and its use for targeted therapy" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,928, issued on May 12, was assigned to Seoul National University R&DB Foundation (Seoul, South Korea) and Sungkwang Medical Foundation (Seoul... और पढ़ें


US Patent Issued to SyzygyMed on May 12 for "Genetically engineered hematopoietic stem cells and uses thereof" (Massachusetts, Illinois Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,929, issued on May 12, was assigned to SyzygyMed Inc. (Anacortes, Wash.). "Genetically engineered hematopoietic stem cells and uses thereof"... और पढ़ें


US Patent Issued to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY on May 12 for "Pharmaceutical composition for preventing or treating brain disease, comprising stem cell-derived exosome surface-modified with compound capable of binding to dopamine receptors or L-amino acid transporters" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,930, issued on May 12, was assigned to RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (Suwon-si, South Korea). "Pharmaceutical compo... और पढ़ें


US Patent Issued to BEAM THERAPEUTICS on May 12 for "Compositions and methods for treating alpha-1 antitrypsin deficiency" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,931, issued on May 12, was assigned to BEAM THERAPEUTICS INC. (Cambridge, Mass.). "Compositions and methods for treating alpha-1 antitrypsin... और पढ़ें


US Patent Issued to Sinai Health System on May 12 for "Immunomodulatory cells and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,932, issued on May 12, was assigned to Sinai Health System (Toronto). "Immunomodulatory cells and uses thereof" was invented by Andras Nagy ... और पढ़ें


US Patent Issued to LAIMU on May 12 for "Method for improving eye condition" (Japanese Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,933, issued on May 12, was assigned to LAIMU Corp. (Yokohama, Japan). "Method for improving eye condition" was invented by Sachio Wakayama (... और पढ़ें


US Patent Issued to ENTEROBIOME on May 12 for "Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,934, issued on May 12, was assigned to ENTEROBIOME INC. (Goyang-si, South Korea). "Pharmaceutical composition for preventing or treating ato... और पढ़ें


US Patent Issued to VALO THERAPEUTICS on May 12 for "Modified oncolytic adenoviruses" (Finnish Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,935, issued on May 12, was assigned to VALO THERAPEUTICS OY (Helsinki). "Modified oncolytic adenoviruses" was invented by Tuuli Ranki (Helsi... और पढ़ें